These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9102384)

  • 1. [Hepatitis C--clinical aspects, diagnosis and therapy].
    Mörl M
    Fortschr Med; 1997 Jan; 115(3):26-9. PubMed ID: 9102384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatitis C, diagnosis and therapy].
    Moradpour D; Blum HE
    Med Klin (Munich); 1996 Dec; 91(12):769-70. PubMed ID: 9082162
    [No Abstract]   [Full Text] [Related]  

  • 3. [The successful treatment of chronic active hepatitis due to hepatitis C viral infection with alpha-interferon and a cytokine complex (a clinical case)].
    Karpov VV; Krel' PE
    Ter Arkh; 1995; 67(5):84-5. PubMed ID: 7638792
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.
    Olaso V; Córdoba J; Berenguer M; Prieto M; Lainez B; Argüello L; Valverde J; Pascual S; Gobernado M; Berenguer J
    Rev Esp Enferm Dig; 1997 Jul; 89(7):531-50. PubMed ID: 9265839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Predictive factors of response to interferon-alpha treatment in chronic hepatitis C].
    Buti M; Esteban R
    Rev Esp Enferm Dig; 1997 Jul; 89(7):501-2. PubMed ID: 9303619
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis C virus infection in dialysis patients.
    Sułowicz W; Radziszewski A; Chowaniec E
    Hemodial Int; 2007 Jul; 11(3):286-95. PubMed ID: 17576291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic hepatitis. Differential diagnosis and therapy. 2: Differential hepatitis C diagnosis].
    Schlaak JF; Gerken G
    Fortschr Med; 1997 Jul; 115(20-21):38-9. PubMed ID: 9333584
    [No Abstract]   [Full Text] [Related]  

  • 8. Parameters predicting response to alpha-interferon treatment in chronic hepatitis C.
    Glück T; Seelig R; Dette S; Bühring HJ; Renz M; Kwon S; Wiedmann KH; Weber P
    Hepatogastroenterology; 1997; 44(14):484-91. PubMed ID: 9164523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective comparison of four lymphoblastoid interferon alpha schedules for chronic hepatitis C. A multivariate analysis of factors predictive of sustained response to treatment.
    Bellobuono A; Mondazzi L; Tempini S; Silini E; Idéo G
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1169-77. PubMed ID: 9471022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy in chronic hepatitis C: say goodbye to the 6-month interferon regimen.
    Koff RS
    Am J Gastroenterol; 1996 Oct; 91(10):2072-4. PubMed ID: 8855723
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy.
    Mels GC; Roffi L; Antonelli G; Bellati G; Pacchetti S; Di Nolfo MA; Panizzuti F; Moretti G; Piperno A; Pozzi M
    Prog Clin Biol Res; 1993; 382():359-64. PubMed ID: 8502704
    [No Abstract]   [Full Text] [Related]  

  • 12. [Epidemiologic studies and treatment of chronic viral hepatitis C].
    Ouzan D
    Med Trop (Mars); 1994; 54(3 Suppl):18-20. PubMed ID: 7596256
    [No Abstract]   [Full Text] [Related]  

  • 13. Large dose natural interferon alpha therapy for patients with chronic hepatitis C.
    Ohmiya M; Hayashi J; Furusyo N; Ueno K; Kishihara Y; Nabeshima S; Kashiwagi S
    Fukuoka Igaku Zasshi; 1997 Dec; 88(12):380-8. PubMed ID: 9465478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus infection: an overview.
    Hwang SJ
    J Microbiol Immunol Infect; 2001 Dec; 34(4):227-34. PubMed ID: 11825001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of hepatitis C: patients with normal aminotransferase levels.
    Marcellin P; Lévy S; Erlinger S
    Hepatology; 1997 Sep; 26(3 Suppl 1):133S-136S. PubMed ID: 9305678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatitis C. Virology, transmission modes, clinical aspects, prevention and therapy].
    Laufs R; Polywka S; Feucht HH; Schröter M; Zöllner B; Oehler G
    Anaesthesist; 2002 Nov; 51(11):884-9. PubMed ID: 12434261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy of hepatitis C: patients with cirrhosis.
    Schalm SW; Fattovich G; Brouwer JT
    Hepatology; 1997 Sep; 26(3 Suppl 1):128S-132S. PubMed ID: 9305677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The management of acute hepatitis C and needlestick accidents with hepatitis-C virus positive blood].
    Cooreman MP; Weegink C; Reesink HW
    Ned Tijdschr Geneeskd; 1998 Oct; 142(42):2298-300. PubMed ID: 9864524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Viral hepatitis C].
    Janković S
    Med Pregl; 1999; 52(11-12):459-63. PubMed ID: 10748768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.